DongKook Pharmaceutical Co., Ltd. (KOSDAQ:086450)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Beauty Device	8.26B	3.58B	-	-	-
Cosmetics	39.00B	9.23B	-	-	-
Pharmaceuticals	897.25B	814.72B	740.09B	675.32B	618.05B
Elimination of Inter-Segment Profits	-17.63B	-15.36B	-9.10B	-13.67B	-23.86B
Total	926.88B	812.17B	730.99B	661.65B	594.19B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Overseas	80.44B	54.01B	71.86B	67.89B	73.30B
South Korea	846.45B	758.15B	659.13B	593.76B	520.89B
Total	926.88B	812.17B	730.99B	661.65B	594.19B

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error